1. Home
  2. RAMP vs NVCR Comparison

RAMP vs NVCR Comparison

Compare RAMP & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$24.32

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.99

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAMP
NVCR
Founded
2018
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1987
2015

Fundamental Metrics

Financial Performance
Metric
RAMP
NVCR
Price
$24.32
$10.99
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$35.60
$27.75
AVG Volume (30 Days)
722.8K
2.4M
Earning Date
02-05-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
86614.23
N/A
EPS
1.05
N/A
Revenue
$795,572,000.00
$642,269,000.00
Revenue This Year
$11.07
$10.64
Revenue Next Year
$9.11
$5.37
P/E Ratio
$23.26
N/A
Revenue Growth
9.18
11.17
52 Week Low
$21.71
$9.82
52 Week High
$35.20
$22.95

Technical Indicators

Market Signals
Indicator
RAMP
NVCR
Relative Strength Index (RSI) 39.32 53.89
Support Level $22.69 $9.82
Resistance Level $25.25 $14.97
Average True Range (ATR) 1.17 0.78
MACD 0.09 0.04
Stochastic Oscillator 39.61 54.56

Price Performance

Historical Comparison
RAMP
NVCR

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: